L E A D E R S H I P
Chief Executive Officer
As CEO, Yuri is responsible for overseeing all aspects of Geneva Healthcare’s business including communicating and implementing the company’s overall vision and strategy.
Yuri has over 15 years of experience in the information technology industry with a specific focus on healthcare and the public sector. Prior to joining Geneva Healthcare’s executive team, Yuri was VP of Sales of Anakam, Inc., an internet security company that also had success in the healthcare and public sector verticals. Yuri was responsible for driving triple-digit product sales revenue growth, achieving 519% revenue growth in 2009 and 312% revenue growth in 2010, placing Anakam on the Inc. 500 Fastest Growing Companies in America list at #116. In 2010, as part of the executive management team, Yuri participated in the merger between Anakam and Equifax and stayed on at Equifax to run sales for the Anakam business unit. His experience includes product management and sales management roles at Microstrategy, Siebel, Oracle, Symantec, and most recently at Okta, a cloud-based identity and access management company.
Yuri holds a Masters of Arts in International Development with a focus in Development Economics from the American University in Washington, D.C. He received his Bachelor of Arts in History and Political Science from the University of California, Santa Barbara.
MANISH WADHWA MD
Chief Medical Officer
Dr. Manish Wadhwa is an actively practicing, board certified Cardiologist and Cardiac Electrophysiologist in San Diego, CA. As Geneva’s Chief Scientific Officer and Co-Founder, Dr. Wadhwa ensures the Geneva Suite brings clinical and workflow value to its customers.
After interviewing for medical school at the age of 16, Dr. Wadhwa enrolled at Penn State University’s Thomas Jefferson Medical College Six Year BSc-MD Program. Upon completion, Dr. Wadhwa trained in Internal Medicine and General Cardiology at Thomas Jefferson University Hospital in Philadelphia, PA. He completed his Cardiology training with 2 years of advanced fellowship in Cardiac Electrophysiology at the University of California at San Diego. Dr. Wadhwa has expertise in both implanted device management and follow-up, as well as, invasive and non-invasive treatments of arrhythmias. He has been serving the San Diego community in private practice since 2000.
Dr. Wadhwa also is or has recently served on Physician Advisory Boards for Medtronic, Boston Scientific, Biotronik, St. Jude Medical, and Sanofi-Aventis. He also is a fellow of the Heart Rhythm Society. Dr. Wadhwa has been an author on over 10 medical papers and has also lectured extensively on clinical issues within Cardiac Electrophysiology. He has been and continues to be involved with several post-market evaluations of commercially available implanted device leads and generators.
Chief Financial Officer
Earl Bray serves as Geneva’s Chief Financial Officer, where he oversees the financial management of the company, business support, financial reporting, controllership functions and financial planning & analysis.
Earl started his career as a CPA with Ernst & Young. He has over 25 years of experience managing the financial operations of both start-up/growth companies and larger global companies. He has extensive M&A, financial services, and healthcare experience. Prior to joining Geneva, Earl was Vice President of Finance for American Express. He has held CFO roles within Blue Cross and Blue Shield, National Health Enhancements Systems, Homebid.com and Surplusbid.com.
Chief Technology Officer
Jeff has over 16 years of experience in the information technology space with a specific focus on enterprise mission critical technology design in the media and entertainment and financial services sector. Prior to joining Geneva Healthcare, Jeff worked for 10 years at FOX where he was directly responsible for designing and building scalable enterprise cloud solutions including traditional hardware based technology platforms. Recently Jeff was IT Director of Cloud Computing and Operations at Fox Entertainment group where he was focused on designing scalable enterprise hybrid cloud services while managing a global server operation teams responsible for 2,000+ servers. Jeff was also the Director of Cloud Computing for Fox Networks Group as the enterprise architect building cloud service solutions with full disaster recovery for Tier 1 applications and single sign-on integration with many 3rd party cloud SAS providers. His experience in the financial services sector includes design and deployment of mission critical trading systems, disaster recovery, and global call center phone systems.
RN MSN CFACCA
Clinical Operations Advisor
Renee Mazeroll was the Vice President, Cardiovascular Services Sharp Healthcare, San Diego, California and joins Geneva to help provide subject matter expertise in all areas of clinical operations.. Renee joined Sharp in April of 2012 bringing approximately 30 years of operational and programmatic experience. Prior to that Renee functioned as the Executive Director of Cardiac, Pulmonary & Vascular Services at St. Joseph Hospital (SJH) in Orange, CA. In addition to the above Renee has been a part time instructor for the UOP graduate and undergraduate nursing program since 2008. Renee is the 2007 recipient of the GE Healthcare Award for Excellence awarded by the American College of Cardiovascular Administrators and the 2014 Vanguard Award awarded by the American Academy of Medical Administrators for leadership.
RN BSN CCDS
Clinical Operations Advisor
Debra Halligan RN BSN CCDS
Deb Halligan is the clinical leader of the pacemaker/ICD clinic at North Shore Medical Center in Salem, MA. She has been responsible for providing and managing the care of patients with a pacemaker, loop recorder, and ICD. She was one of the early adopters or remote monitoring and has created and implemented a successful home monitoring (HM) practice for all ICD, loop and PM patients. She established safe home monitoring guidelines, created alert protocols, standardized the alert system across four vendors, and educated staff, physicians, and patients to the utilization of remote monitoring. She has presented on HM at Heart Rhythm Society in 2013, 2014, and will be presenting again in 2017. Her practice has been considered the gold standard by her peers during a 2012 roundtable discussion for Cardiovascular Business Journal. She has also written several articles for EP Lab Digest, sharing best practice. Deb joins Geneva Healthcare to provide her expertise in building their service model for remote monitoring.
MD PhD FACC FHRS
Clinical Operations Advisor
Dr. Anderson is an Associate Professor in Division of Cardiovascular Medicine, Department of Internal Medicine at the University of Nebraska Medical Center. He is currently an Electrophysiology staff member and Chief and Medical Director of the Section of Cardiac Electorphysiology. He received his Doctorate of Medicine and his Doctorate of Philosophy in Molecular and Cellular Biology at the University of Nebraska Medical Center. His internal medicine and cardiovascular clinical training programs were performed at the University of Nebraska Medical Center.
Dr. Anderson’s specific clinical interests include understanding the aspects and contributing factors involved in atrial and ventricular arrhythmias, as well as in atherosclerosis and ischemic cardiomyopathy. Such arrhythmias are conditions in which the electrical activity of the heart is irregular, is faster or slower than normal and can be life threatening.
Molecular and cellular immunology is the foundation of Dr. Anderson’s research. Dr. Anderson has a specific focus and interest in innate immunity (preexisting immunity) and how such immune responses contribute to the mechanisms of cardiovascular disease processes. His studies have specifically focused on underlying mechanisms of viral myocarditis, atherosclerotic disease and the impact inflammation has on cardiac rhythm abnormalities. Recent studies have detailed the role of inflammation in arrhythmogenesis and atherosclerosis. Dr. Anderson has also detailed the utility of microbubble technology in the detection and monitoring of vascular inflammation.